Skip to main content
Premium Trial:

Request an Annual Quote

Barnes wise to bioinformatics ways

Premium

Over the past 15 months, Julie Barnes left the pharmaceutical industry, where she had worked in drug discovery for 14 years, became a director of life sciences, and gave birth. “It means being very efficient with your time,” she says.

Her new life sciences position is at BioWisdom, a Cambridge, UK-based bioinformatics company. The company provides clients with access to databases that catalogue genomic and other life sciences information, including proteomics, SNPs, and a compound’s chemistry and distribution throughout the body.

Barnes comes from GlaxoSmithKline, where she was head of neuropharmacology research. Faced with many possible targets, she learned how crucial it is to have access to the right information in order to focus on the most promising agent.

Barnes says she took the new job in order to use her discovery experience to provide customers with all the information they need to best target new therapies. “It’s a big change for me in many ways, but actually it’s building on my experience,” she says.

— Alison McCook

 

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.